Bayer: Diabetes Mellitus trials
The registry lists 18 Diabetes Mellitus studies with Bayer as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 2 1Phase 3 4No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Aflibercept Injection in Vision Impairment Due to DMECompletedNCT01331681Phase 3Results posted
- A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve PainCompletedNCT05219812Phase 2
- A Study to Learn How Well a Monitoring System Called Continuous Glucose Monitoring (CGM) Which Measures Glucose on an Ongoing Basis Works and How Safe it is in Chinese Patients in Usual PracticeCompletedNCT05038761
- A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their DiseaseCompletedNCT03161912
- Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin MonotherapyWithdrawnNCT01961388
- GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life PracticeWithdrawnNCT01915264
- Special Drug Use Investigation of Glucobay ODCompletedNCT01685502
- Diabetes Treatment With Glucobay in Combination With SulfonylureaCompletedNCT01613105
- Diabetes Treatment With Glucobay in Combination With MetforminCompletedNCT01612741
- Study To Assess the Dietary Carbohydrate Content of Indian Diabetic PopulationCompletedNCT01450592
- Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney DiseaseCompletedNCT01363336
- Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life SettingCompletedNCT01333774
- GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal InsulinCompletedNCT01248481
- Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular DiseaseCompletedNCT01167231
- Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary CareCompletedNCT01010100Phase 3
- GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient GroupsCompletedNCT00909051
- BAY38-9456 - Pivotal Trial for Diabetes PatientCompletedNCT00678704Phase 3
- Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or HyperlipidemiaCompletedNCT00668109Phase 3